Discovery Of Antibodies Effective Against All Dengue Strains Holds Vaccine Promise, Study Says

Bloomberg News: Mosquito-Borne Dengue Targeted by Antibody With Hope for Vaccine
“Scientists have discovered new antibodies that neutralize viruses that cause dengue, potentially putting a universal vaccine within reach for a mosquito-borne illness that strikes an estimated 400 million people a year. The antibodies are effective against all four dengue viruses, according to an article published [Monday] in Nature Immunology…” (Staley, 12/15).

The Guardian: Dengue fever vaccine on the cards after novel antibody discovery
“…The researchers spotted the new group of antibodies while they were studying blood drawn from patients who picked up dengue infections in South-East Asia. … In follow-up work reported in the study, the scientists went on to manufacture a batch of the human antibodies. Once they have cleared trials, these could be used to treat dengue fever, or administered to protect people against the virus…” (Sample, 12/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.